Alice Finkelstein

During her time in the Njoo group at ASDRP, Alice was a part of the chemical neuroscience subgroup where she helped synthesize and test the activity of analogs of rivastigmine, a drug used to treat neurodegenerative diseases. This work was published in the Journal of Emerging Investigators (https://emerginginvestigators.org/articles/modular-mimics-of-neuroactive-alkaloids-design-synthesis-and-cholinesterase-inhibitory-activity-of-rivastigmine-analogs). Alice was also in the NNRTI subgroup, where she worked on optimizing the Buchwald-Hartwig cross-coupling reaction to synthesize and screen a library of N,N-diaryl pyrimidine-2,4-diamines with the goal of terminating viral HIV reproduction.